Fluorescence in-situ hybridization analysis for melanoma diagnosis

Histopathology

Volumn 60, Issue 5, 2012, Pages 706-714

  Senetta, Rebecca ^a   Paglierani, Milena ^b   Massi, Daniela ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Atypical spitz tumour; FISH; Melanoma

Indexed keywords

CYCLIN D1; PROTEIN MYB;

CELL DIFFERENTIATION; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSTIC PROCEDURE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; HUMAN; MEDICAL LITERATURE; MELANOMA; MOLECULAR DIAGNOSIS; MOLECULAR PROBE; NEVUS; PRIORITY JOURNAL; RELIABILITY; REVIEW; RREB1 GENE; SENSITIVITY AND SPECIFICITY;

CHROMOSOME ABERRATIONS; DIAGNOSIS, DIFFERENTIAL; DNA, NEOPLASM; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MELANOMA; NEVUS; SKIN NEOPLASMS;

EID: 84858996803     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03984.x     Document Type: Review

References (40)

1. Scolyer RA, Shaw HM, Thompson JF et al. Interobserver reproducibility of histopathologic prognostic variables in primary cutaneous melanomas. Am. J. Surg. Pathol. 2003; 27; 1571-1576.
2. Scolyer RA, Murali R, McCarthy SW, Thompson JF. Histologically ambiguous ('borderline') primary cutaneous melanocytic tumors: approaches to patient management including the roles of molecular testing and sentinel lymph node biopsy. Arch. Pathol. Lab. Med. 2010; 134; 1770-1777.
3. Trent JM. Cytogenetics of human malignant melanoma. Cancer Metast. Rev. 1991; 10; 103-113.
4. Mertens F, Johansson B, Hoglund M, Mitelman F. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res. 1997; 57; 2765-2780.
5. Bastian BC, LeBoit PE, Hamm H, Brocker EB, Pinkel D. Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization. Cancer Res. 1998; 58; 2170-2175.
6. Balazs M, Adam Z, Treszl A, Begany A, Hunyadi J, Adany R. Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization. Cytometry 2001; 46; 222-232.
7. Palmieri G, Capone M, Ascierto ML et al. Main roads to melanoma. J. Transl. Med. 2009; 7; 86.
8. Bastian BC, Olshen AB, LeBoit PE, Pinkel D. Classifying melanocytic tumors based on DNA copy number changes. Am. J. Pathol. 2003; 163; 1765-1770.
9. Casorzo L, Luzzi C, Nardacchione A, Picciotto F, Pisacane A, Risio M. Fluorescence in situ hybridization (FISH) evaluation of chromosomes 6, 7, 9 and 10 throughout human melanocytic tumorigenesis. Melanoma Res. 2005; 15; 155-160.
10. Carless MA, Griffiths LR. Cytogenetics of melanoma and nonmelanoma skin cancer. Adv. Exp. Med. Biol. 2008; 624; 227-240.
11. Pirker C, Holzmann K, Spiegl-Kreinecker S et al. Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes. Melanoma Res. 2003; 13; 483-492.
12. Bastian BC. Molecular genetics of melanocytic neoplasia: practical applications for diagnosis. Pathology 2004; 36; 458-461.
13. Bauer J, Bastian BC. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol. Ther. 2006; 19; 40-49.
14. Rakosy Z, Vizkeleti L, Ecsedi S et al. Characterization of 9p21 copy number alterations in human melanoma by fluorescence in situ hybridization. Cancer Genet. Cytogenet. 2008; 182; 116-121.
15. Namiki T, Yanagawa S, Izumo T et al. Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome. Cancer Genet. Cytogenet. 2005; 157; 1-11.
16. Braun-Falco M, Schempp W, Weyers W. Molecular diagnosis in dermatopathology: what makes sense, and what doesn't. Exp. Dermatol. 2009; 18; 12-23.
17. Blokx WA, Van Dijk MC, Ruiter DJ. Molecular cytogenetics of cutaneous melanocytic lesions - diagnostic, prognostic and therapeutic aspects. Histopathology 2010; 56; 121-132.
18. Pfeifer JD. Molecular pathology and patient care. Missouri Med. 2010; 107; 86-93.
19. Wolff AC, Hammond ME, Schwartz JN et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch. Pathol. Lab. Med. 2007; 131; 18-43.
20. Zimmermann AK, Hirschmann A, Pfeiffer D, Paredes BE, Diebold J. FISH analysis for diagnostic evaluation of challenging melanocytic lesions. Histol. Histopathol. 2010; 25; 1139-1147.
21. Gerami P, Jewell SS, Morrison LE et al. Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma. Am. J. Surg. Pathol. 2009; 33; 1146-1156.
22. Gerami P, Mafee M, Lurtsbarapa T, Guitart J, Haghighat Z, Newman M. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes. Arch. Dermatol. 2010; 146; 273-278.
23. Clemente C, Bettio D, Venci A et al. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions. Pathologica 2009; 101; 169-174.
24. Morey AL, Murali R, McCarthy SW, Mann GJ, Scolyer RA. Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation. Pathology 2009; 41; 383-387.
25. Boi S, Leonardi E, Fasanella S, Cantaloni C, Micciolo R. The four-color FISH probe in the diagnosis of melanocytic lesions. J. Eur. Acad. Dermatol. Venereol. 2010; 24; 1235-1236.
26. Newman MD, Lertsburapa T, Mirzabeigi M, Mafee M, Guitart J, Gerami P. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma. Mod. Pathol. 2009; 22; 989-995.
27. Gerami P, Wass A, Mafee M, Fang Y, Pulitzer MP, Busam KJ. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi. Am. J. Surg. Pathol. 2009; 33; 1783-1788.
28. Dalton SR, Gerami P, Kolaitis NA et al. Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma. Am. J. Surg. Pathol. 2010; 34; 231-237.
29. Gerami P, Beilfuss B, Haghighat Z, Fang Y, Jhanwar S, Busam KJ. Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi. J. Cutan. Pathol. 2011; 38; 329-334.
30. Pouryazdanparast P, Newman M, Mafee M, Haghighat Z, Guitart J, Gerami P. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization. Am. J. Surg. Pathol. 2009; 33; 1396-1400.
31. Gammon B, Beilfuss B, Guitart J, Busam KJ, Gerami P. Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus-like melanoma. J. Cutan. Pathol. 2011; 38; 335-341.
32. Busam KJ, Fang Y, Jhanwar SC, Pulitzer MP, Marr B, Abramson DH. Distinction of conjunctival melanocytic nevi from melanomas by fluorescence in situ hybridization. J. Cutan. Pathol. 2010; 37; 196-203.
33. Gerami P, Barnhill RL, Beilfuss BA, LeBoit P, Schneider P, Guitart J. Superficial melanocytic neoplasms with pagetoid melanocytosis: a study of interobserver concordance and correlation with FISH. Am. J. Surg. Pathol. 2010; 34; 816-821.
34. Newman MD, Mirzabeigi M, Gerami P. Chromosomal copy number changes supporting the classification of lentiginous junctional melanoma of the elderly as a subtype of melanoma. Mod. Pathol. 2009; 22; 1258-1262.
35. McCalmont TH. Gone FISHing. J. Cutan. Pathol. 2010; 37; 193-195.
36. Song J, Mooi WJ, Petronic-Rosic V, Shea CR, Stricker T, Krausz T. Nevus versus melanoma: to FISH, or not to FISH. Adv. Anat. Pathol. 2011; 18; 229-234.
37. Vergier B, Prochazkova-Carlotti M, De la Fouchardiere A et al. Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 cases. Mod. Pathol. 2010; 24; 613-623.
38. Gaiser T, Kutzner H, Palmedo G et al. Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up. Mod. Pathol. 2010; 23; 413-419.
39. Raskin L, Ludgate M, Iyer RK et al. Copy number variations and clinical outcome in atypical spitz tumors. Am. J. Surg. Pathol. 2011; 35; 243-252.
40. Massi D, Cesinaro AM, Tomasini C et al. Atypical Spitzoid melanocytic tumors: a morphological, mutational, and FISH analysis. J. Am. Acad. Dermatol. 2011; 64; 919-935.